Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery

Cancer

Volumn 88, Issue 2, 2000, Pages 398-406

  Brenner, David J ^a   Curtis, Rochelle E ^b   Hall, Eric J ^a   Ron, Elaine ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Prostate carcinoma; Radiation; Second malignancies; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SECOND CANCER;

ADULT; AGE OF ONSET; AGED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 0034650837     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V     Document Type: Article

References (39)

1. Curtis RE. Second cancers following radiotherapy for cancer. In: Boice JD Jr., editor. Implications of new data on radiation cancer risk. Proceedings of the 32nd Annual Meeting of the National Council on Radiation Protection and Measurements. Bethesda: NCRP Publications; 1997:79-94.
2. Boice JD Jr, Travis LB. Body wars: effect of friendly fire. J Natl Cancer Inst 1995;87:705-6.
3. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
4. Brenner DJ, Hall EJ. Making the radiotherapy decision. Los Angeles: Lowell Press, 1996.
5. Zucali R, Luini A, Del Vecchio M, Sacchini V, Sverzellati E, Stucchi C, et al. Contralateral breast cancer after limited surgery plus radiotherapy of early mammary tumors. Eur J Surg Oncol 1987;13:413-7.
6. Johnstone PA, Powell CR, Riffenburgh R, Rohde DC, Kane CJ. Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year followup. J Urol 1998;159:946-9.
7. Movsas B, Hanlon AL, Pinover W, Hanks GE. Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys 1998;41:251-5.
8. Liskow AS, Romas N, Ozzello L, Suarez R, Veenema R, Chang CH. Multiple primary tumors in association with prostatic cancer. Cancer 1984;54:2549-55.
9. Kleinerman RA, Boice JD Jr., Storm HH, Sparen P, Andersen A, Pukkala E, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 1995;76:442-52.
10. Curtis RE, Boice JD Jr., Stovall M, Bernstein L, Holowaty E, Karjalainen S, et al. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. J Natl Cancer Inst 1994;86:1315-24.
11. Hankey BF, Curtis RE, Naughton MD, Boice JD Jr., Flannery JT. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 1983;70: 797-804.
12. Neugut AI, Ahsan H, Robinson E, Ennis RD. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 1997;79:1600-4.
13. Pawlish KS, Schottenfeld D, Severson R, Montie JE. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study. Prostate 1997;33:75-86.
14. Boice JD Jr., Curtis RE, Kleinerman RA, Flannery JT, Fraumeni JF Jr. Multiple primary cancers in Connecticut, 1935-82. Yale J Biol Med 1986;59:533-45.
15. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, editors. SEER Cancer Statistics Review 1973-1994. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1997 DHHS Pub No. (NIH) 97-2789.
16. Mettlin CJ, Murphy GP, Sylvester J, McKee RF, Morrow M, Winchester DP. Results of hospital cancer registry surveys by the American College of Surgeons. Outcomes of prostate cancer treatment by radical prostatectomy. Cancer 1997;80: 1875-81.
17. Breslow NE. The design and analysis of cohort studies Lyon: International Agency for Research on Cancer, 1987.
18. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1679-84.
19. Kleinerman RA, Liebermann JV, Li FP. Second cancer following cancer of the male genital system in Connecticut, 1935-82. Monogr Natl Cancer Inst 1985;68:139-47.
20. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res 1994;137(2 Suppl):S17-67.
21. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137(2 Suppl):S68-97.
22. Mole RH, Papworth DG, Corp MJ. The dose-response for x-ray induction of myeloid leukaemia in male CBA/H mice. Br J Cancer 1983;47:285-91.
23. Brenner DJ. The influence of cell killing on radiation oncogenesis: possible implications for high-LET risk assessment at medium doses. Health Phys 1993;65:358-66.
24. Boice JD Jr., Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988; 116:3-55.
25. Kuttesch JF Jr., Wexler LH, Marcus RB, Fairclough D, Weaver-McClure L, White M, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14:2818-25.
26. Wong FL, Boice JD Jr., Abramson DH, Tarone RE, Kleinerman RA, Stovall M, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278: 1262-7.
27. Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 1998;77:370-7.
28. Brown JM. The effect of acute x-irradiation on the cell proliferation kinetics of induced carcinomas and their normal counterpart. Radiat Res 1970;43:627-53.
29. Leibel SA, Hanks GE, Kramer S. Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1984;10:401-9.
30. Francois P, Beurtheret C, Dutreix A. Calculation of the dose delivered to organs outside the radiation beams. Med Phys 1988;15:879-83.
31. Khuri SF, Daley J, Henderson W, Barbour G, Lowry P, Irvin G, et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 1995;180:519-31.
32. Rohan TE, Hislop TG, Howe GR, Gallagher RP, Teh CZ, Ghadirian P. Cigarette smoking and risk of prostate cancer: a population-based case-control study in Ontario and British Columbia, Canada. Eur J Cancer Prev 1997;6:382-8.
33. Boice JD Jr., Day NE, Andersen A, Brinton LA, Brown R, Choi NW, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985;74:955-75.
34. Storm H, Jensen OM. Second primary cancers among 40,518 women treated for cancer or carcinoma in situ of the cervix. In: Day NE, Boice JD Jr., editors. Second cancer in relation to radiation treatment for cervical cancer. Lyon: International Agency for Research on Cancer, 1983:59-69.
35. Stovall M, Blackwell CR, Cundiff J, Novack DH, Palta JR, Wagner LK, et al. Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys 1995;22:63-82.
36. Zietman AL, Owen J, Mougham J, Katz A, Mahon I, Hanks GE. Radiation practice patterns for men with cancer of the prostate. The 1994 patterns of care study [abstract]. Int J Radiat Oncol Biol Phys 1998;42(Suppl 1):290.
37. Hall EJ, Martin SG, Amols HI, Hei TK. Photoneutrons from medical linear accelerators - radiobiological measurements and risk estimates. Int J Radiat Oncol Biol Phys 1995;33:225-30.
38. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
39. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 1999;5:152-8.